跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pandemic Influenza Vaccine H5N1 Baxter Suspension for Injection - HSA Drug Approval Details
Approvals
/
HSA
/
Pandemic Influenza Vaccine H5N1 Baxter Suspension for Injection
Approved
THERAPEUTIC
Pandemic Influenza Vaccine H5N1 Baxter Suspension for Injection
Baxter AG
🇸🇬 Health Sciences Authority
Approval Date
Dec 19, 2012
Approval ID
4107571c67c5d15d
Company
Baxter AG
Type
Therapeutic
Approval Details
Approval Id
4107571c67c5d15d
Drug Name
Pandemic Influenza Vaccine H5N1 Baxter Suspension for Injection
Product Name
Pandemic Influenza Vaccine H5N1 Baxter Suspension for Injection
Approval Number
SIN14278P
Approval Date
2012-12-19
Registrant
PHARMENG TECHNOLOGY PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SUSPENSION
Route Of Administration
INTRAMUSCULAR
Atc Code
J07BB01
Atc Item Name
influenza, inactivated, whole virus
Pharma Manufacturer Name
PHARMENG TECHNOLOGY PTE. LTD.
Company Detail Path
/organization/pharmeng-technology-pte-ltd
Active Ingredients
A/Vietnam/1203/2004 (H5N1)
7.5µg haemagglutinin per 0.5ml
A/Vietnam/1203/2004 (H5N1)
7.5µg haemagglutinin per 0.5ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 19, 2012
Approval ID
4107571c67c5d15d
Type
Therapeutic
Back to HSA Approvals
